GHM Tumor Marker US Tumor Markers Rapid Test (FIA) – Quantitative, 15-Minute, Whole Blood/Serum/Plasma

SKU: GHM Tumor Marker US
Brand: Global Healthcare Medical

Product Overview

Global Healthcare Medical GHM Tumor Marker US Tumor Markers Rapid Test (FIA) is a fluorescence immunoassay (FIA) designed for the quantitative determination of tumor markers in human whole blood, serum, or plasma samples. Tumor markers are substances produced by cancer cells or by other cells of the body in response to cancer. The measurement of tumor markers is used as an aid in the management and monitoring of tumor patients, including monitoring of treatment response, prognostication, and detection of recurrence.

The GHM Tumor Marker US is intended for use with the FIA Analyzer (VIM01), a compact benchtop analyzer that utilizes fluorescence immunochromatography technology. The analyzer features auto calibration, barcode identification, and a built-in memory capacity of 50,000 results. The analyzer delivers reliable results in 10 ± 5 seconds after the test device is inserted.

The system is designed for professional use in clinical laboratories, hospitals, and clinics. The FIA analyzer operates with a small sample volume and provides fast, reliable results with simple operation.

This product is for in vitro diagnostic use only. For professional use only.

Key Features & Benefits

Quantitative Tumor Marker Measurement – Aid in Tumor Patient Management

The GHM Tumor Marker US delivers quantitative tumor marker results, providing measurable concentration values that can be used as an aid in the continuous monitoring of tumor marker levels and the treatment and management of tumor patients. Tumor marker tests are useful for monitoring treatment efficacy, prognosis assessment, and recurrence detection.

Comprehensive Test Menu – Broad Tumor Marker Coverage

The GHM Tumor Marker US supports detection of a comprehensive panel of tumor markers, providing broad coverage for clinical oncology testing needs.

Clinical Applications by Marker:

Multiple panel configurations available. Contact Global Healthcare Medical for the complete test menu and panel customization options.

Sandwich Immunodetection Method – Fluorescence Immunoassay Principle

The GHM Tumor Marker US uses a sandwich immunodetection method. When the sample is added to the sample well of the test device, fluorescence-labeled detector antibodies bind to tumor marker antigens in the specimen. As the sample mixture migrates on the nitrocellulose matrix of the test strip by capillary action, the complexes of detector antibody and tumor marker antigen are captured by immobilized antibodies at specific test lines on the strip. Thus, the more tumor marker antigen in the specimen, the more complexes accumulate on the test strip. Signal intensity of fluorescence of detector antibody reflects the amount of tumor marker captured, and the FIA Analyzer displays the tumor marker concentration in the specimen.

FIA Analyzer – Advanced Technical Platform

The GHM Tumor Marker US is used with the FIA Analyzer (VIM01), a compact fluorescence immunoassay analyzer featuring auto calibration, barcode identification, and a large memory capacity. The analyzer can detect 30+ parameters by auto-scanning the code chip.

Wide Storage Temperature – No Cold Chain Required

The test kit is designed for convenient storage and transport, with a storage temperature range of 2 ~ 30°C, eliminating the need for cold chain logistics.

Simple Operation – Professional Laboratory Testing

The test procedure involves three simple steps: mix the sample with buffer, add the mixed specimen, and insert the device into the analyzer.

Product Specifications

Why Clinical Laboratories Choose Global Healthcare Medical